nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—SLC22A1—Cladribine—multiple sclerosis	0.0432	0.0672	CbGbCtD
Verapamil—ABCC10—Methotrexate—multiple sclerosis	0.0432	0.0672	CbGbCtD
Verapamil—ABCC1—Mitoxantrone—multiple sclerosis	0.04	0.0623	CbGbCtD
Verapamil—ABCG2—Cladribine—multiple sclerosis	0.0367	0.0571	CbGbCtD
Verapamil—SLCO1A2—Prednisolone—multiple sclerosis	0.0314	0.0489	CbGbCtD
Verapamil—SLCO1A2—Prednisone—multiple sclerosis	0.0297	0.0462	CbGbCtD
Verapamil—ABCB11—Dexamethasone—multiple sclerosis	0.0292	0.0454	CbGbCtD
Verapamil—ABCC3—Methotrexate—multiple sclerosis	0.0272	0.0423	CbGbCtD
Verapamil—ABCG2—Mitoxantrone—multiple sclerosis	0.0268	0.0417	CbGbCtD
Verapamil—ABCC4—Methotrexate—multiple sclerosis	0.0207	0.0323	CbGbCtD
Verapamil—CYP2D6—Fingolimod—multiple sclerosis	0.0194	0.0301	CbGbCtD
Verapamil—SLCO1A2—Dexamethasone—multiple sclerosis	0.0185	0.0288	CbGbCtD
Verapamil—ABCC1—Methotrexate—multiple sclerosis	0.0167	0.0259	CbGbCtD
Verapamil—ABCC2—Dexamethasone—multiple sclerosis	0.0154	0.0239	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—multiple sclerosis	0.0149	0.0232	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—multiple sclerosis	0.014	0.0219	CbGbCtD
Verapamil—ABCG2—Dexamethasone—multiple sclerosis	0.0139	0.0216	CbGbCtD
Verapamil—ABCB1—Methylprednisolone—multiple sclerosis	0.0132	0.0206	CbGbCtD
Verapamil—ABCC2—Methotrexate—multiple sclerosis	0.0123	0.0192	CbGbCtD
Verapamil—CYP3A4—Fingolimod—multiple sclerosis	0.0123	0.0192	CbGbCtD
Verapamil—ABCG2—Methotrexate—multiple sclerosis	0.0112	0.0174	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0103	0.016	CbGbCtD
Verapamil—CYP3A7—Dexamethasone—multiple sclerosis	0.0103	0.016	CbGbCtD
Verapamil—CYP2C19—Prednisone—multiple sclerosis	0.00994	0.0155	CbGbCtD
Verapamil—CYP2B6—Dexamethasone—multiple sclerosis	0.00977	0.0152	CbGbCtD
Verapamil—ABCB1—Mitoxantrone—multiple sclerosis	0.00966	0.015	CbGbCtD
Verapamil—ABCB1—Betamethasone—multiple sclerosis	0.00861	0.0134	CbGbCtD
Verapamil—ABCB1—Prednisolone—multiple sclerosis	0.00849	0.0132	CbGbCtD
Verapamil—ABCB1—Prednisone—multiple sclerosis	0.00802	0.0125	CbGbCtD
Verapamil—CYP3A4—Methylprednisolone—multiple sclerosis	0.00793	0.0123	CbGbCtD
Verapamil—CYP3A5—Dexamethasone—multiple sclerosis	0.00769	0.012	CbGbCtD
Verapamil—CYP2C8—Dexamethasone—multiple sclerosis	0.0074	0.0115	CbGbCtD
Verapamil—CYP2C19—Dexamethasone—multiple sclerosis	0.00621	0.00966	CbGbCtD
Verapamil—CYP3A4—Triamcinolone—multiple sclerosis	0.00601	0.00935	CbGbCtD
Verapamil—CYP3A4—Mitoxantrone—multiple sclerosis	0.00579	0.009	CbGbCtD
Verapamil—CYP2C9—Dexamethasone—multiple sclerosis	0.00516	0.00803	CbGbCtD
Verapamil—CYP3A4—Betamethasone—multiple sclerosis	0.00516	0.00802	CbGbCtD
Verapamil—CYP3A4—Prednisolone—multiple sclerosis	0.00509	0.00792	CbGbCtD
Verapamil—ABCB1—Dexamethasone—multiple sclerosis	0.00501	0.00779	CbGbCtD
Verapamil—CYP3A4—Prednisone—multiple sclerosis	0.00481	0.00748	CbGbCtD
Verapamil—CYP2D6—Dexamethasone—multiple sclerosis	0.00472	0.00734	CbGbCtD
Verapamil—CACNA1A—nerve—multiple sclerosis	0.00444	0.0584	CbGeAlD
Verapamil—ABCB1—Methotrexate—multiple sclerosis	0.00402	0.00626	CbGbCtD
Verapamil—CYP3A4—Dexamethasone—multiple sclerosis	0.003	0.00467	CbGbCtD
Verapamil—CACNA1F—retina—multiple sclerosis	0.00293	0.0385	CbGeAlD
Verapamil—CACNA1A—brainstem—multiple sclerosis	0.00191	0.0251	CbGeAlD
Verapamil—CACNB4—medulla oblongata—multiple sclerosis	0.00139	0.0183	CbGeAlD
Verapamil—CACNA1A—medulla oblongata—multiple sclerosis	0.00133	0.0175	CbGeAlD
Verapamil—CACNA1B—medulla oblongata—multiple sclerosis	0.0013	0.0171	CbGeAlD
Verapamil—CACNB4—midbrain—multiple sclerosis	0.00127	0.0167	CbGeAlD
Verapamil—CACNB4—spinal cord—multiple sclerosis	0.00124	0.0163	CbGeAlD
Verapamil—CACNA1I—cerebellum—multiple sclerosis	0.0012	0.0157	CbGeAlD
Verapamil—CACNA1B—midbrain—multiple sclerosis	0.00119	0.0156	CbGeAlD
Verapamil—CACNA1B—spinal cord—multiple sclerosis	0.00116	0.0152	CbGeAlD
Verapamil—CACNB1—medulla oblongata—multiple sclerosis	0.00111	0.0146	CbGeAlD
Verapamil—CACNB3—medulla oblongata—multiple sclerosis	0.00107	0.014	CbGeAlD
Verapamil—CACNB4—nervous system—multiple sclerosis	0.00105	0.0138	CbGeAlD
Verapamil—CACNB1—midbrain—multiple sclerosis	0.00102	0.0134	CbGeAlD
Verapamil—CACNB4—central nervous system—multiple sclerosis	0.00101	0.0133	CbGeAlD
Verapamil—CACNA1A—nervous system—multiple sclerosis	0.000999	0.0131	CbGeAlD
Verapamil—CACNB1—spinal cord—multiple sclerosis	0.000992	0.013	CbGeAlD
Verapamil—CACNB2—retina—multiple sclerosis	0.000991	0.013	CbGeAlD
Verapamil—CACNB4—cerebellum—multiple sclerosis	0.000984	0.013	CbGeAlD
Verapamil—CACNA1B—nervous system—multiple sclerosis	0.000975	0.0128	CbGeAlD
Verapamil—CACNB3—midbrain—multiple sclerosis	0.000975	0.0128	CbGeAlD
Verapamil—CACNA1I—brain—multiple sclerosis	0.000972	0.0128	CbGeAlD
Verapamil—CACNA1A—central nervous system—multiple sclerosis	0.000962	0.0127	CbGeAlD
Verapamil—CACNA1A—cerebellum—multiple sclerosis	0.00094	0.0124	CbGeAlD
Verapamil—CACNA1B—central nervous system—multiple sclerosis	0.000939	0.0124	CbGeAlD
Verapamil—CACNA1B—cerebellum—multiple sclerosis	0.000917	0.0121	CbGeAlD
Verapamil—CACNA1G—nervous system—multiple sclerosis	0.000871	0.0115	CbGeAlD
Verapamil—CACNA1G—central nervous system—multiple sclerosis	0.000839	0.011	CbGeAlD
Verapamil—CACNB1—nervous system—multiple sclerosis	0.000835	0.011	CbGeAlD
Verapamil—CACNA1G—cerebellum—multiple sclerosis	0.00082	0.0108	CbGeAlD
Verapamil—CACNB1—central nervous system—multiple sclerosis	0.000804	0.0106	CbGeAlD
Verapamil—CACNB3—nervous system—multiple sclerosis	0.000801	0.0105	CbGeAlD
Verapamil—CACNB4—brain—multiple sclerosis	0.0008	0.0105	CbGeAlD
Verapamil—CACNB1—cerebellum—multiple sclerosis	0.000786	0.0103	CbGeAlD
Verapamil—CACNB3—central nervous system—multiple sclerosis	0.000771	0.0102	CbGeAlD
Verapamil—CACNA1A—brain—multiple sclerosis	0.000763	0.01	CbGeAlD
Verapamil—CACNB3—cerebellum—multiple sclerosis	0.000754	0.00992	CbGeAlD
Verapamil—CACNA1B—brain—multiple sclerosis	0.000745	0.00981	CbGeAlD
Verapamil—CACNA1G—brain—multiple sclerosis	0.000666	0.00877	CbGeAlD
Verapamil—CACNB1—brain—multiple sclerosis	0.000639	0.0084	CbGeAlD
Verapamil—SLC6A4—brainstem—multiple sclerosis	0.000625	0.00823	CbGeAlD
Verapamil—CACNB3—brain—multiple sclerosis	0.000612	0.00806	CbGeAlD
Verapamil—CACNA1H—nervous system—multiple sclerosis	0.00057	0.0075	CbGeAlD
Verapamil—CACNB2—nervous system—multiple sclerosis	0.000538	0.00709	CbGeAlD
Verapamil—CACNA1H—cerebellum—multiple sclerosis	0.000536	0.00706	CbGeAlD
Verapamil—ABCC10—medulla oblongata—multiple sclerosis	0.000523	0.00689	CbGeAlD
Verapamil—CACNB2—central nervous system—multiple sclerosis	0.000518	0.00682	CbGeAlD
Verapamil—KCNJ11—nervous system—multiple sclerosis	0.000511	0.00672	CbGeAlD
Verapamil—CACNB2—cerebellum—multiple sclerosis	0.000507	0.00667	CbGeAlD
Verapamil—KCNJ11—central nervous system—multiple sclerosis	0.000492	0.00647	CbGeAlD
Verapamil—KCNJ11—cerebellum—multiple sclerosis	0.000481	0.00633	CbGeAlD
Verapamil—ABCC10—midbrain—multiple sclerosis	0.000478	0.0063	CbGeAlD
Verapamil—CACNA1D—nervous system—multiple sclerosis	0.000471	0.00619	CbGeAlD
Verapamil—ABCC10—spinal cord—multiple sclerosis	0.000467	0.00614	CbGeAlD
Verapamil—CACNA1D—central nervous system—multiple sclerosis	0.000453	0.00596	CbGeAlD
Verapamil—SLCO1A2—medulla oblongata—multiple sclerosis	0.000451	0.00594	CbGeAlD
Verapamil—SLC22A5—retina—multiple sclerosis	0.00045	0.00593	CbGeAlD
Verapamil—CACNA1D—cerebellum—multiple sclerosis	0.000443	0.00583	CbGeAlD
Verapamil—SLC22A4—spinal cord—multiple sclerosis	0.000439	0.00577	CbGeAlD
Verapamil—CACNA1H—brain—multiple sclerosis	0.000436	0.00574	CbGeAlD
Verapamil—CACNA1C—nervous system—multiple sclerosis	0.000434	0.00572	CbGeAlD
Verapamil—SCN5A—nervous system—multiple sclerosis	0.000421	0.00554	CbGeAlD
Verapamil—CACNA1C—central nervous system—multiple sclerosis	0.000418	0.0055	CbGeAlD
Verapamil—SLCO1A2—midbrain—multiple sclerosis	0.000412	0.00543	CbGeAlD
Verapamil—CACNB2—brain—multiple sclerosis	0.000412	0.00542	CbGeAlD
Verapamil—CACNA1C—cerebellum—multiple sclerosis	0.000409	0.00538	CbGeAlD
Verapamil—SCN5A—central nervous system—multiple sclerosis	0.000405	0.00533	CbGeAlD
Verapamil—SLCO1A2—spinal cord—multiple sclerosis	0.000402	0.00529	CbGeAlD
Verapamil—SLC6A4—midbrain—multiple sclerosis	0.000398	0.00524	CbGeAlD
Verapamil—ABCC3—nervous system—multiple sclerosis	0.000395	0.0052	CbGeAlD
Verapamil—KCNJ11—brain—multiple sclerosis	0.00039	0.00514	CbGeAlD
Verapamil—SLC6A4—spinal cord—multiple sclerosis	0.000389	0.00511	CbGeAlD
Verapamil—ABCC3—central nervous system—multiple sclerosis	0.00038	0.00501	CbGeAlD
Verapamil—ABCC10—cerebellum—multiple sclerosis	0.00037	0.00487	CbGeAlD
Verapamil—CACNA1D—brain—multiple sclerosis	0.00036	0.00473	CbGeAlD
Verapamil—SLC22A1—nervous system—multiple sclerosis	0.000352	0.00463	CbGeAlD
Verapamil—SLC22A4—cerebellum—multiple sclerosis	0.000348	0.00458	CbGeAlD
Verapamil—KCNH2—medulla oblongata—multiple sclerosis	0.000344	0.00453	CbGeAlD
Verapamil—SLCO1A2—nervous system—multiple sclerosis	0.000339	0.00446	CbGeAlD
Verapamil—SLC22A1—central nervous system—multiple sclerosis	0.000339	0.00446	CbGeAlD
Verapamil—CACNA1C—brain—multiple sclerosis	0.000332	0.00437	CbGeAlD
Verapamil—SLC6A4—nervous system—multiple sclerosis	0.000327	0.00431	CbGeAlD
Verapamil—SLCO1A2—central nervous system—multiple sclerosis	0.000326	0.00429	CbGeAlD
Verapamil—ABCC4—nervous system—multiple sclerosis	0.000326	0.00429	CbGeAlD
Verapamil—SLC22A5—medulla oblongata—multiple sclerosis	0.000326	0.00428	CbGeAlD
Verapamil—SCN5A—brain—multiple sclerosis	0.000322	0.00423	CbGeAlD
Verapamil—SLCO1A2—cerebellum—multiple sclerosis	0.000319	0.0042	CbGeAlD
Verapamil—SLC6A4—central nervous system—multiple sclerosis	0.000315	0.00415	CbGeAlD
Verapamil—KCNH2—midbrain—multiple sclerosis	0.000315	0.00414	CbGeAlD
Verapamil—ABCC4—central nervous system—multiple sclerosis	0.000314	0.00413	CbGeAlD
Verapamil—KCNH2—spinal cord—multiple sclerosis	0.000307	0.00404	CbGeAlD
Verapamil—ABCG2—medulla oblongata—multiple sclerosis	0.000306	0.00403	CbGeAlD
Verapamil—ABCC3—brain—multiple sclerosis	0.000302	0.00398	CbGeAlD
Verapamil—CYP2D6—brainstem—multiple sclerosis	0.000301	0.00397	CbGeAlD
Verapamil—ABCC10—brain—multiple sclerosis	0.000301	0.00396	CbGeAlD
Verapamil—SLC22A5—midbrain—multiple sclerosis	0.000298	0.00392	CbGeAlD
Verapamil—SLC22A5—spinal cord—multiple sclerosis	0.00029	0.00382	CbGeAlD
Verapamil—SLC22A4—brain—multiple sclerosis	0.000283	0.00372	CbGeAlD
Verapamil—ABCG2—midbrain—multiple sclerosis	0.00028	0.00369	CbGeAlD
Verapamil—ABCG2—spinal cord—multiple sclerosis	0.000273	0.0036	CbGeAlD
Verapamil—SLC22A1—brain—multiple sclerosis	0.000269	0.00354	CbGeAlD
Verapamil—ABCC1—cerebellum—multiple sclerosis	0.000262	0.00344	CbGeAlD
Verapamil—SLCO1A2—brain—multiple sclerosis	0.000259	0.00341	CbGeAlD
Verapamil—KCNH2—nervous system—multiple sclerosis	0.000259	0.00341	CbGeAlD
Verapamil—SLC6A4—brain—multiple sclerosis	0.00025	0.00329	CbGeAlD
Verapamil—ABCC4—brain—multiple sclerosis	0.000249	0.00328	CbGeAlD
Verapamil—KCNH2—central nervous system—multiple sclerosis	0.000249	0.00328	CbGeAlD
Verapamil—KCNH2—cerebellum—multiple sclerosis	0.000244	0.00321	CbGeAlD
Verapamil—SLC22A5—cerebellum—multiple sclerosis	0.00023	0.00303	CbGeAlD
Verapamil—ABCG2—cerebellum—multiple sclerosis	0.000217	0.00285	CbGeAlD
Verapamil—ABCC1—brain—multiple sclerosis	0.000213	0.0028	CbGeAlD
Verapamil—CYP2B6—nervous system—multiple sclerosis	0.000212	0.0028	CbGeAlD
Verapamil—ABCB1—retina—multiple sclerosis	0.000209	0.00275	CbGeAlD
Verapamil—CYP2B6—central nervous system—multiple sclerosis	0.000205	0.00269	CbGeAlD
Verapamil—KCNH2—brain—multiple sclerosis	0.000198	0.0026	CbGeAlD
Verapamil—SLC22A5—brain—multiple sclerosis	0.000187	0.00246	CbGeAlD
Verapamil—CYP2C8—brain—multiple sclerosis	0.000181	0.00238	CbGeAlD
Verapamil—Constipation—Mitoxantrone—multiple sclerosis	0.000178	0.00107	CcSEcCtD
Verapamil—Pain—Mitoxantrone—multiple sclerosis	0.000178	0.00107	CcSEcCtD
Verapamil—Bradycardia—Prednisone—multiple sclerosis	0.000178	0.00107	CcSEcCtD
Verapamil—Alopecia—Dexamethasone—multiple sclerosis	0.000177	0.00107	CcSEcCtD
Verapamil—Alopecia—Betamethasone—multiple sclerosis	0.000177	0.00107	CcSEcCtD
Verapamil—Diarrhoea—Azathioprine—multiple sclerosis	0.000176	0.00106	CcSEcCtD
Verapamil—Discomfort—Prednisolone—multiple sclerosis	0.000176	0.00106	CcSEcCtD
Verapamil—ABCG2—brain—multiple sclerosis	0.000176	0.00232	CbGeAlD
Verapamil—Angioedema—Triamcinolone—multiple sclerosis	0.000176	0.00106	CcSEcCtD
Verapamil—Angioedema—Methylprednisolone—multiple sclerosis	0.000176	0.00106	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000175	0.00105	CcSEcCtD
Verapamil—Vertigo—Triamcinolone—multiple sclerosis	0.000173	0.00104	CcSEcCtD
Verapamil—Syncope—Triamcinolone—multiple sclerosis	0.000173	0.00104	CcSEcCtD
Verapamil—Vertigo—Methylprednisolone—multiple sclerosis	0.000173	0.00104	CcSEcCtD
Verapamil—Syncope—Methylprednisolone—multiple sclerosis	0.000172	0.00104	CcSEcCtD
Verapamil—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000172	0.00103	CcSEcCtD
Verapamil—Oedema—Prednisolone—multiple sclerosis	0.000171	0.00103	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000171	0.00103	CcSEcCtD
Verapamil—Dizziness—Azathioprine—multiple sclerosis	0.00017	0.00103	CcSEcCtD
Verapamil—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00017	0.00102	CcSEcCtD
Verapamil—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000169	0.00102	CcSEcCtD
Verapamil—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000169	0.00102	CcSEcCtD
Verapamil—Shock—Prednisolone—multiple sclerosis	0.000168	0.00101	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000168	0.00101	CcSEcCtD
Verapamil—Convulsion—Triamcinolone—multiple sclerosis	0.000167	0.00101	CcSEcCtD
Verapamil—Tachycardia—Prednisolone—multiple sclerosis	0.000167	0.00101	CcSEcCtD
Verapamil—Convulsion—Methylprednisolone—multiple sclerosis	0.000166	0.001	CcSEcCtD
Verapamil—Hypertension—Triamcinolone—multiple sclerosis	0.000166	0.001	CcSEcCtD
Verapamil—Hypertension—Methylprednisolone—multiple sclerosis	0.000166	0.001	CcSEcCtD
Verapamil—Urticaria—Mitoxantrone—multiple sclerosis	0.000165	0.000998	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000165	0.000996	CcSEcCtD
Verapamil—Myalgia—Triamcinolone—multiple sclerosis	0.000164	0.000988	CcSEcCtD
Verapamil—Vomiting—Azathioprine—multiple sclerosis	0.000164	0.000988	CcSEcCtD
Verapamil—Arthralgia—Methylprednisolone—multiple sclerosis	0.000164	0.000986	CcSEcCtD
Verapamil—Myalgia—Methylprednisolone—multiple sclerosis	0.000164	0.000986	CcSEcCtD
Verapamil—Drowsiness—Methotrexate—multiple sclerosis	0.000163	0.000981	CcSEcCtD
Verapamil—Rash—Azathioprine—multiple sclerosis	0.000162	0.000979	CcSEcCtD
Verapamil—CYP2B6—brain—multiple sclerosis	0.000162	0.00214	CbGeAlD
Verapamil—Dermatitis—Azathioprine—multiple sclerosis	0.000162	0.000979	CcSEcCtD
Verapamil—Flushing—Prednisone—multiple sclerosis	0.000162	0.000978	CcSEcCtD
Verapamil—Discomfort—Triamcinolone—multiple sclerosis	0.000162	0.000976	CcSEcCtD
Verapamil—Discomfort—Methylprednisolone—multiple sclerosis	0.000162	0.000974	CcSEcCtD
Verapamil—Headache—Azathioprine—multiple sclerosis	0.000161	0.000973	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000161	0.000973	CcSEcCtD
Verapamil—CYP3A4—nervous system—multiple sclerosis	0.00016	0.00211	CbGeAlD
Verapamil—Dry mouth—Triamcinolone—multiple sclerosis	0.00016	0.000967	CcSEcCtD
Verapamil—Angioedema—Dexamethasone—multiple sclerosis	0.00016	0.000962	CcSEcCtD
Verapamil—Angioedema—Betamethasone—multiple sclerosis	0.00016	0.000962	CcSEcCtD
Verapamil—Confusional state—Methylprednisolone—multiple sclerosis	0.000158	0.000953	CcSEcCtD
Verapamil—CYP2D6—nervous system—multiple sclerosis	0.000158	0.00208	CbGeAlD
Verapamil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000157	0.000947	CcSEcCtD
Verapamil—Oedema—Triamcinolone—multiple sclerosis	0.000157	0.000947	CcSEcCtD
Verapamil—Vertigo—Dexamethasone—multiple sclerosis	0.000157	0.000946	CcSEcCtD
Verapamil—Vertigo—Betamethasone—multiple sclerosis	0.000157	0.000946	CcSEcCtD
Verapamil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000157	0.000945	CcSEcCtD
Verapamil—Syncope—Dexamethasone—multiple sclerosis	0.000157	0.000945	CcSEcCtD
Verapamil—Syncope—Betamethasone—multiple sclerosis	0.000157	0.000945	CcSEcCtD
Verapamil—Infection—Triamcinolone—multiple sclerosis	0.000156	0.000941	CcSEcCtD
Verapamil—Sweating—Methotrexate—multiple sclerosis	0.000156	0.00094	CcSEcCtD
Verapamil—Infection—Methylprednisolone—multiple sclerosis	0.000156	0.000939	CcSEcCtD
Verapamil—Shock—Triamcinolone—multiple sclerosis	0.000155	0.000932	CcSEcCtD
Verapamil—Insomnia—Prednisolone—multiple sclerosis	0.000155	0.000932	CcSEcCtD
Verapamil—Alopecia—Prednisone—multiple sclerosis	0.000154	0.000931	CcSEcCtD
Verapamil—CYP3A4—central nervous system—multiple sclerosis	0.000154	0.00203	CbGeAlD
Verapamil—Shock—Methylprednisolone—multiple sclerosis	0.000154	0.00093	CcSEcCtD
Verapamil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000154	0.000926	CcSEcCtD
Verapamil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000154	0.000926	CcSEcCtD
Verapamil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000153	0.000925	CcSEcCtD
Verapamil—Paraesthesia—Prednisolone—multiple sclerosis	0.000153	0.000925	CcSEcCtD
Verapamil—Tachycardia—Triamcinolone—multiple sclerosis	0.000153	0.000925	CcSEcCtD
Verapamil—Nausea—Azathioprine—multiple sclerosis	0.000153	0.000923	CcSEcCtD
Verapamil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000153	0.000923	CcSEcCtD
Verapamil—CYP2D6—central nervous system—multiple sclerosis	0.000152	0.002	CbGeAlD
Verapamil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000152	0.000916	CcSEcCtD
Verapamil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000152	0.000914	CcSEcCtD
Verapamil—Convulsion—Dexamethasone—multiple sclerosis	0.000151	0.000913	CcSEcCtD
Verapamil—Convulsion—Betamethasone—multiple sclerosis	0.000151	0.000913	CcSEcCtD
Verapamil—ABCB1—medulla oblongata—multiple sclerosis	0.000151	0.00199	CbGeAlD
Verapamil—Hypertension—Betamethasone—multiple sclerosis	0.000151	0.000909	CcSEcCtD
Verapamil—Hypertension—Dexamethasone—multiple sclerosis	0.000151	0.000909	CcSEcCtD
Verapamil—Asthenia—Mitoxantrone—multiple sclerosis	0.000149	0.000901	CcSEcCtD
Verapamil—Myalgia—Betamethasone—multiple sclerosis	0.000149	0.000897	CcSEcCtD
Verapamil—Myalgia—Dexamethasone—multiple sclerosis	0.000149	0.000897	CcSEcCtD
Verapamil—CYP2D6—cerebellum—multiple sclerosis	0.000149	0.00195	CbGeAlD
Verapamil—Discomfort—Betamethasone—multiple sclerosis	0.000147	0.000886	CcSEcCtD
Verapamil—Discomfort—Dexamethasone—multiple sclerosis	0.000147	0.000886	CcSEcCtD
Verapamil—Hypotension—Methylprednisolone—multiple sclerosis	0.000147	0.000883	CcSEcCtD
Verapamil—Pain—Prednisolone—multiple sclerosis	0.000146	0.000881	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—multiple sclerosis	0.000146	0.000881	CcSEcCtD
Verapamil—Pharyngitis—Methotrexate—multiple sclerosis	0.000145	0.000874	CcSEcCtD
Verapamil—Vision blurred—Prednisone—multiple sclerosis	0.000143	0.000865	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000143	0.000863	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000143	0.000861	CcSEcCtD
Verapamil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000143	0.00086	CcSEcCtD
Verapamil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000143	0.00086	CcSEcCtD
Verapamil—Oedema—Betamethasone—multiple sclerosis	0.000143	0.00086	CcSEcCtD
Verapamil—Oedema—Dexamethasone—multiple sclerosis	0.000143	0.00086	CcSEcCtD
Verapamil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000143	0.000859	CcSEcCtD
Verapamil—Insomnia—Triamcinolone—multiple sclerosis	0.000142	0.000857	CcSEcCtD
Verapamil—Insomnia—Methylprednisolone—multiple sclerosis	0.000142	0.000855	CcSEcCtD
Verapamil—Infection—Dexamethasone—multiple sclerosis	0.000142	0.000854	CcSEcCtD
Verapamil—Infection—Betamethasone—multiple sclerosis	0.000142	0.000854	CcSEcCtD
Verapamil—Paraesthesia—Triamcinolone—multiple sclerosis	0.000141	0.000851	CcSEcCtD
Verapamil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000141	0.000849	CcSEcCtD
Verapamil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000141	0.000849	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—multiple sclerosis	0.000141	0.000849	CcSEcCtD
Verapamil—Shock—Betamethasone—multiple sclerosis	0.00014	0.000846	CcSEcCtD
Verapamil—Shock—Dexamethasone—multiple sclerosis	0.00014	0.000846	CcSEcCtD
Verapamil—Dyspnoea—Triamcinolone—multiple sclerosis	0.00014	0.000845	CcSEcCtD
Verapamil—Agitation—Prednisone—multiple sclerosis	0.00014	0.000843	CcSEcCtD
Verapamil—Tachycardia—Betamethasone—multiple sclerosis	0.000139	0.000839	CcSEcCtD
Verapamil—Tachycardia—Dexamethasone—multiple sclerosis	0.000139	0.000839	CcSEcCtD
Verapamil—Angioedema—Prednisone—multiple sclerosis	0.000139	0.000838	CcSEcCtD
Verapamil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000138	0.000834	CcSEcCtD
Verapamil—ABCB1—midbrain—multiple sclerosis	0.000138	0.00182	CbGeAlD
Verapamil—Erythema multiforme—Methotrexate—multiple sclerosis	0.000138	0.000833	CcSEcCtD
Verapamil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000138	0.000832	CcSEcCtD
Verapamil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000138	0.000831	CcSEcCtD
Verapamil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000138	0.000831	CcSEcCtD
Verapamil—Vertigo—Prednisone—multiple sclerosis	0.000137	0.000824	CcSEcCtD
Verapamil—Syncope—Prednisone—multiple sclerosis	0.000136	0.000823	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—multiple sclerosis	0.000136	0.000821	CcSEcCtD
Verapamil—Urticaria—Prednisolone—multiple sclerosis	0.000136	0.000818	CcSEcCtD
Verapamil—Fatigue—Triamcinolone—multiple sclerosis	0.000135	0.000817	CcSEcCtD
Verapamil—Fatigue—Methylprednisolone—multiple sclerosis	0.000135	0.000815	CcSEcCtD
Verapamil—ABCB1—spinal cord—multiple sclerosis	0.000135	0.00177	CbGeAlD
Verapamil—Pain—Triamcinolone—multiple sclerosis	0.000134	0.00081	CcSEcCtD
Verapamil—Loss of consciousness—Prednisone—multiple sclerosis	0.000134	0.000806	CcSEcCtD
Verapamil—Hypotension—Betamethasone—multiple sclerosis	0.000133	0.000803	CcSEcCtD
Verapamil—Hypotension—Dexamethasone—multiple sclerosis	0.000133	0.000803	CcSEcCtD
Verapamil—Vomiting—Mitoxantrone—multiple sclerosis	0.000132	0.000798	CcSEcCtD
Verapamil—Convulsion—Prednisone—multiple sclerosis	0.000132	0.000795	CcSEcCtD
Verapamil—Hypertension—Prednisone—multiple sclerosis	0.000131	0.000792	CcSEcCtD
Verapamil—Rash—Mitoxantrone—multiple sclerosis	0.000131	0.000792	CcSEcCtD
Verapamil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000131	0.000791	CcSEcCtD
Verapamil—Headache—Mitoxantrone—multiple sclerosis	0.00013	0.000787	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00013	0.000783	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00013	0.000783	CcSEcCtD
Verapamil—Arthralgia—Prednisone—multiple sclerosis	0.00013	0.000781	CcSEcCtD
Verapamil—Myalgia—Prednisone—multiple sclerosis	0.00013	0.000781	CcSEcCtD
Verapamil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000129	0.000781	CcSEcCtD
Verapamil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000129	0.000779	CcSEcCtD
Verapamil—Alopecia—Methotrexate—multiple sclerosis	0.000129	0.000778	CcSEcCtD
Verapamil—Insomnia—Betamethasone—multiple sclerosis	0.000129	0.000778	CcSEcCtD
Verapamil—Insomnia—Dexamethasone—multiple sclerosis	0.000129	0.000778	CcSEcCtD
Verapamil—Paraesthesia—Betamethasone—multiple sclerosis	0.000128	0.000772	CcSEcCtD
Verapamil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000128	0.000772	CcSEcCtD
Verapamil—Discomfort—Prednisone—multiple sclerosis	0.000128	0.000772	CcSEcCtD
Verapamil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000126	0.000759	CcSEcCtD
Verapamil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000126	0.000757	CcSEcCtD
Verapamil—Dyspepsia—Betamethasone—multiple sclerosis	0.000126	0.000757	CcSEcCtD
Verapamil—Urticaria—Triamcinolone—multiple sclerosis	0.000125	0.000753	CcSEcCtD
Verapamil—Urticaria—Methylprednisolone—multiple sclerosis	0.000125	0.000751	CcSEcCtD
Verapamil—Oedema—Prednisone—multiple sclerosis	0.000124	0.000749	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000124	0.000749	CcSEcCtD
Verapamil—Nausea—Mitoxantrone—multiple sclerosis	0.000124	0.000746	CcSEcCtD
Verapamil—Infection—Prednisone—multiple sclerosis	0.000123	0.000744	CcSEcCtD
Verapamil—Fatigue—Dexamethasone—multiple sclerosis	0.000123	0.000741	CcSEcCtD
Verapamil—Fatigue—Betamethasone—multiple sclerosis	0.000123	0.000741	CcSEcCtD
Verapamil—Shock—Prednisone—multiple sclerosis	0.000122	0.000737	CcSEcCtD
Verapamil—Pain—Betamethasone—multiple sclerosis	0.000122	0.000735	CcSEcCtD
Verapamil—Pain—Dexamethasone—multiple sclerosis	0.000122	0.000735	CcSEcCtD
Verapamil—Tachycardia—Prednisone—multiple sclerosis	0.000121	0.000731	CcSEcCtD
Verapamil—CYP2D6—brain—multiple sclerosis	0.000121	0.00159	CbGeAlD
Verapamil—Hyperhidrosis—Prednisone—multiple sclerosis	0.00012	0.000724	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—multiple sclerosis	0.00012	0.000723	CcSEcCtD
Verapamil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000117	0.000708	CcSEcCtD
Verapamil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000117	0.000708	CcSEcCtD
Verapamil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000116	0.000698	CcSEcCtD
Verapamil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000116	0.000696	CcSEcCtD
Verapamil—Vertigo—Methotrexate—multiple sclerosis	0.000114	0.000689	CcSEcCtD
Verapamil—ABCB1—nervous system—multiple sclerosis	0.000114	0.00149	CbGeAlD
Verapamil—Urticaria—Dexamethasone—multiple sclerosis	0.000113	0.000683	CcSEcCtD
Verapamil—Urticaria—Betamethasone—multiple sclerosis	0.000113	0.000683	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000113	0.000682	CcSEcCtD
Verapamil—Dizziness—Prednisolone—multiple sclerosis	0.000113	0.000681	CcSEcCtD
Verapamil—Asthenia—Triamcinolone—multiple sclerosis	0.000113	0.00068	CcSEcCtD
Verapamil—Asthenia—Methylprednisolone—multiple sclerosis	0.000112	0.000678	CcSEcCtD
Verapamil—Insomnia—Prednisone—multiple sclerosis	0.000112	0.000677	CcSEcCtD
Verapamil—Paraesthesia—Prednisone—multiple sclerosis	0.000111	0.000672	CcSEcCtD
Verapamil—Pruritus—Triamcinolone—multiple sclerosis	0.000111	0.00067	CcSEcCtD
Verapamil—Pruritus—Methylprednisolone—multiple sclerosis	0.000111	0.000669	CcSEcCtD
Verapamil—Convulsion—Methotrexate—multiple sclerosis	0.00011	0.000664	CcSEcCtD
Verapamil—ABCB1—central nervous system—multiple sclerosis	0.000109	0.00144	CbGeAlD
Verapamil—Dyspepsia—Prednisone—multiple sclerosis	0.000109	0.000659	CcSEcCtD
Verapamil—Myalgia—Methotrexate—multiple sclerosis	0.000108	0.000653	CcSEcCtD
Verapamil—Chest pain—Methotrexate—multiple sclerosis	0.000108	0.000653	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—multiple sclerosis	0.000108	0.000653	CcSEcCtD
Verapamil—Rash—Prednisolone—multiple sclerosis	0.000108	0.00065	CcSEcCtD
Verapamil—Dermatitis—Prednisolone—multiple sclerosis	0.000108	0.000649	CcSEcCtD
Verapamil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000107	0.000647	CcSEcCtD
Verapamil—Fatigue—Prednisone—multiple sclerosis	0.000107	0.000645	CcSEcCtD
Verapamil—Headache—Prednisolone—multiple sclerosis	0.000107	0.000645	CcSEcCtD
Verapamil—Discomfort—Methotrexate—multiple sclerosis	0.000107	0.000645	CcSEcCtD
Verapamil—ABCB1—cerebellum—multiple sclerosis	0.000107	0.00141	CbGeAlD
Verapamil—Constipation—Prednisone—multiple sclerosis	0.000106	0.00064	CcSEcCtD
Verapamil—Confusional state—Methotrexate—multiple sclerosis	0.000105	0.000631	CcSEcCtD
Verapamil—Dizziness—Triamcinolone—multiple sclerosis	0.000104	0.000627	CcSEcCtD
Verapamil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000104	0.000626	CcSEcCtD
Verapamil—Dizziness—Methylprednisolone—multiple sclerosis	0.000104	0.000625	CcSEcCtD
Verapamil—Infection—Methotrexate—multiple sclerosis	0.000103	0.000622	CcSEcCtD
Verapamil—Feeling abnormal—Prednisone—multiple sclerosis	0.000102	0.000617	CcSEcCtD
Verapamil—Asthenia—Betamethasone—multiple sclerosis	0.000102	0.000617	CcSEcCtD
Verapamil—Asthenia—Dexamethasone—multiple sclerosis	0.000102	0.000617	CcSEcCtD
Verapamil—Nausea—Prednisolone—multiple sclerosis	0.000101	0.000612	CcSEcCtD
Verapamil—Pruritus—Dexamethasone—multiple sclerosis	0.000101	0.000608	CcSEcCtD
Verapamil—Pruritus—Betamethasone—multiple sclerosis	0.000101	0.000608	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—multiple sclerosis	0.0001	0.000605	CcSEcCtD
Verapamil—Vomiting—Triamcinolone—multiple sclerosis	9.99e-05	0.000602	CcSEcCtD
Verapamil—Vomiting—Methylprednisolone—multiple sclerosis	9.97e-05	0.000601	CcSEcCtD
Verapamil—Rash—Triamcinolone—multiple sclerosis	9.91e-05	0.000597	CcSEcCtD
Verapamil—Dermatitis—Triamcinolone—multiple sclerosis	9.9e-05	0.000597	CcSEcCtD
Verapamil—Rash—Methylprednisolone—multiple sclerosis	9.89e-05	0.000596	CcSEcCtD
Verapamil—Dermatitis—Methylprednisolone—multiple sclerosis	9.88e-05	0.000596	CcSEcCtD
Verapamil—Urticaria—Prednisone—multiple sclerosis	9.86e-05	0.000595	CcSEcCtD
Verapamil—Headache—Triamcinolone—multiple sclerosis	9.84e-05	0.000594	CcSEcCtD
Verapamil—Headache—Methylprednisolone—multiple sclerosis	9.82e-05	0.000592	CcSEcCtD
Verapamil—Diarrhoea—Dexamethasone—multiple sclerosis	9.76e-05	0.000588	CcSEcCtD
Verapamil—Diarrhoea—Betamethasone—multiple sclerosis	9.76e-05	0.000588	CcSEcCtD
Verapamil—Hypotension—Methotrexate—multiple sclerosis	9.7e-05	0.000585	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.45e-05	0.00057	CcSEcCtD
Verapamil—Dizziness—Betamethasone—multiple sclerosis	9.43e-05	0.000568	CcSEcCtD
Verapamil—Dizziness—Dexamethasone—multiple sclerosis	9.43e-05	0.000568	CcSEcCtD
Verapamil—Insomnia—Methotrexate—multiple sclerosis	9.39e-05	0.000566	CcSEcCtD
Verapamil—Nausea—Triamcinolone—multiple sclerosis	9.33e-05	0.000563	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—multiple sclerosis	9.32e-05	0.000562	CcSEcCtD
Verapamil—Nausea—Methylprednisolone—multiple sclerosis	9.31e-05	0.000562	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—multiple sclerosis	9.25e-05	0.000558	CcSEcCtD
Verapamil—Somnolence—Methotrexate—multiple sclerosis	9.23e-05	0.000556	CcSEcCtD
Verapamil—Hypersensitivity—Prednisone—multiple sclerosis	9.15e-05	0.000552	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—multiple sclerosis	9.13e-05	0.000551	CcSEcCtD
Verapamil—Vomiting—Betamethasone—multiple sclerosis	9.07e-05	0.000547	CcSEcCtD
Verapamil—Vomiting—Dexamethasone—multiple sclerosis	9.07e-05	0.000547	CcSEcCtD
Verapamil—Rash—Dexamethasone—multiple sclerosis	8.99e-05	0.000542	CcSEcCtD
Verapamil—Rash—Betamethasone—multiple sclerosis	8.99e-05	0.000542	CcSEcCtD
Verapamil—Dermatitis—Betamethasone—multiple sclerosis	8.98e-05	0.000542	CcSEcCtD
Verapamil—Dermatitis—Dexamethasone—multiple sclerosis	8.98e-05	0.000542	CcSEcCtD
Verapamil—Fatigue—Methotrexate—multiple sclerosis	8.95e-05	0.000539	CcSEcCtD
Verapamil—Headache—Dexamethasone—multiple sclerosis	8.93e-05	0.000539	CcSEcCtD
Verapamil—Headache—Betamethasone—multiple sclerosis	8.93e-05	0.000539	CcSEcCtD
Verapamil—Asthenia—Prednisone—multiple sclerosis	8.91e-05	0.000537	CcSEcCtD
Verapamil—Pain—Methotrexate—multiple sclerosis	8.87e-05	0.000535	CcSEcCtD
Verapamil—Pruritus—Prednisone—multiple sclerosis	8.79e-05	0.00053	CcSEcCtD
Verapamil—ABCB1—brain—multiple sclerosis	8.68e-05	0.00114	CbGeAlD
Verapamil—Feeling abnormal—Methotrexate—multiple sclerosis	8.55e-05	0.000516	CcSEcCtD
Verapamil—Diarrhoea—Prednisone—multiple sclerosis	8.5e-05	0.000512	CcSEcCtD
Verapamil—Nausea—Dexamethasone—multiple sclerosis	8.47e-05	0.000511	CcSEcCtD
Verapamil—Nausea—Betamethasone—multiple sclerosis	8.47e-05	0.000511	CcSEcCtD
Verapamil—Urticaria—Methotrexate—multiple sclerosis	8.24e-05	0.000497	CcSEcCtD
Verapamil—Dizziness—Prednisone—multiple sclerosis	8.21e-05	0.000495	CcSEcCtD
Verapamil—Vomiting—Prednisone—multiple sclerosis	7.89e-05	0.000476	CcSEcCtD
Verapamil—Rash—Prednisone—multiple sclerosis	7.83e-05	0.000472	CcSEcCtD
Verapamil—Dermatitis—Prednisone—multiple sclerosis	7.82e-05	0.000472	CcSEcCtD
Verapamil—Headache—Prednisone—multiple sclerosis	7.78e-05	0.000469	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—multiple sclerosis	7.65e-05	0.000461	CcSEcCtD
Verapamil—Asthenia—Methotrexate—multiple sclerosis	7.45e-05	0.000449	CcSEcCtD
Verapamil—Nausea—Prednisone—multiple sclerosis	7.38e-05	0.000445	CcSEcCtD
Verapamil—Pruritus—Methotrexate—multiple sclerosis	7.34e-05	0.000443	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—multiple sclerosis	7.1e-05	0.000428	CcSEcCtD
Verapamil—Dizziness—Methotrexate—multiple sclerosis	6.86e-05	0.000414	CcSEcCtD
Verapamil—Vomiting—Methotrexate—multiple sclerosis	6.6e-05	0.000398	CcSEcCtD
Verapamil—Rash—Methotrexate—multiple sclerosis	6.54e-05	0.000395	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—multiple sclerosis	6.54e-05	0.000394	CcSEcCtD
Verapamil—Headache—Methotrexate—multiple sclerosis	6.5e-05	0.000392	CcSEcCtD
Verapamil—Nausea—Methotrexate—multiple sclerosis	6.16e-05	0.000372	CcSEcCtD
Verapamil—CACNA1D—Metabolism—BCHE—multiple sclerosis	2.04e-05	0.000177	CbGpPWpGaD
Verapamil—KCNH2—Neuronal System—MAPK1—multiple sclerosis	2.04e-05	0.000177	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—STAT3—multiple sclerosis	2.03e-05	0.000176	CbGpPWpGaD
Verapamil—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.02e-05	0.000175	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SRM—multiple sclerosis	2e-05	0.000173	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—IL6—multiple sclerosis	1.99e-05	0.000173	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—IL6—multiple sclerosis	1.99e-05	0.000172	CbGpPWpGaD
Verapamil—ABCC1—Disease—SLC11A1—multiple sclerosis	1.97e-05	0.00017	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP9—multiple sclerosis	1.96e-05	0.00017	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SRM—multiple sclerosis	1.95e-05	0.000169	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.95e-05	0.000168	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.95e-05	0.000168	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—POMC—multiple sclerosis	1.94e-05	0.000168	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—IL6—multiple sclerosis	1.94e-05	0.000168	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—RRM1—multiple sclerosis	1.93e-05	0.000167	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—RRM1—multiple sclerosis	1.91e-05	0.000166	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.89e-05	0.000164	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.89e-05	0.000164	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—TGFB1—multiple sclerosis	1.88e-05	0.000163	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—MAPK1—multiple sclerosis	1.87e-05	0.000162	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	1.87e-05	0.000162	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	1.87e-05	0.000162	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.87e-05	0.000162	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP9—multiple sclerosis	1.86e-05	0.000161	CbGpPWpGaD
Verapamil—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.86e-05	0.000161	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MAPK1—multiple sclerosis	1.85e-05	0.00016	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	1.85e-05	0.00016	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SRM—multiple sclerosis	1.84e-05	0.000159	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	1.83e-05	0.000159	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SRM—multiple sclerosis	1.83e-05	0.000158	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.82e-05	0.000158	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.82e-05	0.000158	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—POMC—multiple sclerosis	1.82e-05	0.000158	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.82e-05	0.000157	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—BCHE—multiple sclerosis	1.79e-05	0.000155	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.000154	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.77e-05	0.000154	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—ALB—multiple sclerosis	1.77e-05	0.000153	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—TNF—multiple sclerosis	1.76e-05	0.000152	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—ALB—multiple sclerosis	1.76e-05	0.000152	CbGpPWpGaD
Verapamil—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.75e-05	0.000152	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—STAT3—multiple sclerosis	1.74e-05	0.000151	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—IL6—multiple sclerosis	1.73e-05	0.00015	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.71e-05	0.000148	CbGpPWpGaD
Verapamil—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.71e-05	0.000148	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—IL6—multiple sclerosis	1.71e-05	0.000148	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.7e-05	0.000147	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.7e-05	0.000147	CbGpPWpGaD
Verapamil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.69e-05	0.000146	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—BCHE—multiple sclerosis	1.68e-05	0.000145	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.67e-05	0.000145	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—IL6—multiple sclerosis	1.67e-05	0.000145	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.67e-05	0.000144	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—ALB—multiple sclerosis	1.66e-05	0.000144	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.000143	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—STAT3—multiple sclerosis	1.65e-05	0.000143	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP9—multiple sclerosis	1.65e-05	0.000143	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	1.63e-05	0.000141	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.62e-05	0.000141	CbGpPWpGaD
Verapamil—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.62e-05	0.00014	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.62e-05	0.00014	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—IL6—multiple sclerosis	1.62e-05	0.00014	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—TGFB1—multiple sclerosis	1.62e-05	0.00014	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000139	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MAPK1—multiple sclerosis	1.58e-05	0.000137	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.58e-05	0.000137	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.58e-05	0.000137	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD28—multiple sclerosis	1.57e-05	0.000136	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SRM—multiple sclerosis	1.56e-05	0.000135	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.55e-05	0.000134	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.54e-05	0.000134	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TGFB1—multiple sclerosis	1.53e-05	0.000132	CbGpPWpGaD
Verapamil—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.52e-05	0.000132	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—TNF—multiple sclerosis	1.51e-05	0.000131	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MAPK1—multiple sclerosis	1.5e-05	0.00013	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.48e-05	0.000128	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—STAT3—multiple sclerosis	1.47e-05	0.000127	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.46e-05	0.000127	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	1.45e-05	0.000126	CbGpPWpGaD
Verapamil—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.45e-05	0.000125	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.45e-05	0.000125	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—IL6—multiple sclerosis	1.43e-05	0.000124	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TNF—multiple sclerosis	1.43e-05	0.000124	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IL2—multiple sclerosis	1.42e-05	0.000123	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—IL6—multiple sclerosis	1.42e-05	0.000123	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—IL6—multiple sclerosis	1.42e-05	0.000123	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Verapamil—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.4e-05	0.000121	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.39e-05	0.00012	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.00012	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.38e-05	0.000119	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.38e-05	0.000119	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.38e-05	0.000119	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	1.36e-05	0.000118	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	1.34e-05	0.000116	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.33e-05	0.000115	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	1.33e-05	0.000115	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	1.32e-05	0.000114	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.3e-05	0.000112	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.3e-05	0.000112	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—APOE—multiple sclerosis	1.3e-05	0.000112	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.29e-05	0.000112	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.29e-05	0.000111	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.29e-05	0.000111	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TNF—multiple sclerosis	1.27e-05	0.00011	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.27e-05	0.00011	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	0.00011	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000109	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GPC5—multiple sclerosis	1.26e-05	0.000109	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.26e-05	0.000109	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TNF—multiple sclerosis	1.26e-05	0.000109	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—APOE—multiple sclerosis	1.24e-05	0.000107	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—APOE—multiple sclerosis	1.23e-05	0.000106	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—IL6—multiple sclerosis	1.22e-05	0.000105	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.2e-05	0.000104	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SRM—multiple sclerosis	1.2e-05	0.000104	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.2e-05	0.000104	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000104	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.19e-05	0.000103	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.19e-05	0.000103	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.18e-05	0.000102	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—IL6—multiple sclerosis	1.15e-05	9.98e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD86—multiple sclerosis	1.12e-05	9.71e-05	CbGpPWpGaD
Verapamil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.12e-05	9.66e-05	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.12e-05	9.65e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—POMC—multiple sclerosis	1.11e-05	9.65e-05	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TGFB1—multiple sclerosis	1.11e-05	9.62e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—BCHE—multiple sclerosis	1.11e-05	9.6e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.1e-05	9.52e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.1e-05	9.52e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.1e-05	9.51e-05	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—MAPK1—multiple sclerosis	1.09e-05	9.43e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—APOE—multiple sclerosis	1.08e-05	9.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.07e-05	9.3e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.07e-05	9.25e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—POMC—multiple sclerosis	1.06e-05	9.2e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—POMC—multiple sclerosis	1.06e-05	9.14e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—RRM1—multiple sclerosis	1.04e-05	9.03e-05	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.03e-05	8.9e-05	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—IL6—multiple sclerosis	1.02e-05	8.86e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.02e-05	8.85e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ALB—multiple sclerosis	1.02e-05	8.8e-05	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—IL6—multiple sclerosis	1.01e-05	8.77e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—APOE—multiple sclerosis	1.01e-05	8.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.01e-05	8.7e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CCR5—multiple sclerosis	9.95e-06	8.61e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—APOE—multiple sclerosis	9.94e-06	8.61e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.83e-06	8.51e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.75e-06	8.44e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HLA-A—multiple sclerosis	9.69e-06	8.39e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ALB—multiple sclerosis	9.69e-06	8.39e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—APOE—multiple sclerosis	9.67e-06	8.37e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.63e-06	8.33e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ALB—multiple sclerosis	9.62e-06	8.33e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.6e-06	8.31e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.42e-06	8.15e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.29e-06	8.04e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—POMC—multiple sclerosis	9.27e-06	8.03e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—APOE—multiple sclerosis	9.05e-06	7.83e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.97e-06	7.76e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—POMC—multiple sclerosis	8.67e-06	7.5e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—POMC—multiple sclerosis	8.54e-06	7.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.48e-06	7.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.48e-06	7.34e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ALB—multiple sclerosis	8.45e-06	7.32e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—APOE—multiple sclerosis	8.42e-06	7.29e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—RRM1—multiple sclerosis	8.33e-06	7.21e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—POMC—multiple sclerosis	8.31e-06	7.19e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.29e-06	7.18e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD80—multiple sclerosis	8.18e-06	7.08e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—BCHE—multiple sclerosis	8.13e-06	7.03e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.98e-06	6.91e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—BCHE—multiple sclerosis	7.94e-06	6.88e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ALB—multiple sclerosis	7.9e-06	6.84e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ALB—multiple sclerosis	7.79e-06	6.74e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.76e-06	6.72e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—APOE—multiple sclerosis	7.58e-06	6.56e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ALB—multiple sclerosis	7.58e-06	6.56e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.56e-06	6.55e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.28e-06	6.3e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—POMC—multiple sclerosis	7.24e-06	6.26e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—APOE—multiple sclerosis	7.2e-06	6.23e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.13e-06	6.17e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TYK2—multiple sclerosis	6.91e-06	5.98e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.88e-06	5.96e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—APOE—multiple sclerosis	6.67e-06	5.77e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—APOE—multiple sclerosis	6.61e-06	5.72e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ALB—multiple sclerosis	6.6e-06	5.71e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—POMC—multiple sclerosis	6.51e-06	5.64e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.5e-06	5.62e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.5e-06	5.62e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.46e-06	5.59e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.43e-06	5.57e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD4—multiple sclerosis	6.25e-06	5.41e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—POMC—multiple sclerosis	6.19e-06	5.36e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—APOE—multiple sclerosis	6.15e-06	5.33e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.14e-06	5.32e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.03e-06	5.22e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—BCHE—multiple sclerosis	5.99e-06	5.19e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—multiple sclerosis	5.94e-06	5.14e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.92e-06	5.13e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—POMC—multiple sclerosis	5.73e-06	4.96e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—POMC—multiple sclerosis	5.68e-06	4.92e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.65e-06	4.89e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—multiple sclerosis	5.64e-06	4.88e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.6e-06	4.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.55e-06	4.81e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—POMC—multiple sclerosis	5.28e-06	4.57e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—multiple sclerosis	5.22e-06	4.52e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—multiple sclerosis	5.18e-06	4.48e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.06e-06	4.38e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOE—multiple sclerosis	4.89e-06	4.23e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—multiple sclerosis	4.84e-06	4.19e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—multiple sclerosis	4.82e-06	4.17e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—BCHE—multiple sclerosis	4.78e-06	4.14e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOE—multiple sclerosis	4.78e-06	4.14e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—multiple sclerosis	4.49e-06	3.89e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—multiple sclerosis	4.48e-06	3.88e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK1—multiple sclerosis	4.4e-06	3.81e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—POMC—multiple sclerosis	4.2e-06	3.64e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOE—multiple sclerosis	4.14e-06	3.58e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—POMC—multiple sclerosis	4.1e-06	3.55e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—multiple sclerosis	3.83e-06	3.31e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—multiple sclerosis	3.74e-06	3.24e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOE—multiple sclerosis	3.69e-06	3.2e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.69e-06	3.2e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOE—multiple sclerosis	3.61e-06	3.12e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—POMC—multiple sclerosis	3.56e-06	3.08e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOE—multiple sclerosis	3.4e-06	2.94e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—multiple sclerosis	3.38e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOE—multiple sclerosis	3.37e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—multiple sclerosis	3.24e-06	2.81e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—POMC—multiple sclerosis	3.17e-06	2.75e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—POMC—multiple sclerosis	3.1e-06	2.68e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—POMC—multiple sclerosis	2.92e-06	2.53e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—POMC—multiple sclerosis	2.89e-06	2.5e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—multiple sclerosis	2.89e-06	2.5e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOE—multiple sclerosis	2.88e-06	2.49e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—multiple sclerosis	2.82e-06	2.44e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—multiple sclerosis	2.66e-06	2.3e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—multiple sclerosis	2.64e-06	2.28e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—POMC—multiple sclerosis	2.47e-06	2.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—multiple sclerosis	2.25e-06	1.95e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOE—multiple sclerosis	2.22e-06	1.92e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—POMC—multiple sclerosis	1.91e-06	1.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—multiple sclerosis	1.74e-06	1.51e-05	CbGpPWpGaD
